The U.S. Food & Drug Administration (FDA) recently required GlaxoSmithKline, the maker of the popular asthma inhaler Serevent (salmeterol xinafoate) to add new warnings on the product labeling warning of an increased risk of hospitalization and death.
Do I Have a Serevent Lawsuit? If you or a loved one have used a Serevent inhaler and subsequently suffered from a serious injury or unfortunate death, you should contact us immediately. You may be entitled to compensation for your injuries or loss and we can help.
The Problem With LABAs
Serevent belongs to a class of inhalers called Long-Acting Beta-Agonists (LABAs).
Serevent inhalers relax the muscles in bronchial passages, allowing more air to flow. The medication generally provides immediate relief to asthma sufferers but unfortunately, does not treat the underlying inflammation. This creates the risk of a life-threatening condition.